Worldwide Countries outside of the United States and Canada.
Strong career paths and cutting-edge science draw more women scientists — like chemists and engineers — to our small molecule process R&D team Willow Button Badges
Women scientists have historically been underrepresented in the field of process research and development — the space between drug discovery and manufacturing. However, over the past seven years, the percentage of women on our company’s small molecule process research & development (SM PR&D) team has nearly doubled and continues to grow.
“Our group today looks dramatically different than it did when I first started 14 years ago because we’ve taken steps to build more diverse teams,” said McCabe Dunn.
And, women chemists and engineers are vital to our success.
“While we’ve come a long way in the last decade, achieving greater gender equity must continue to be a priority for all leaders,” said Kevin Campos, vice president.
One successful approach has been for women leaders to take more active roles in recruiting talent. This allows for greater relationship building among female candidates applying for jobs in science fields and provides a vision for growth opportunities at our company.
“We’re also expanding relationships with more academic institutions and casting a wider net to find excellent talent,” said McCabe Dunn. “As more women join the company and see the strong career paths open to them, we expect to see even greater diversity.”
Eighteen years ago, when Marguerite Mohan joined Merck, she was one of a small group of women scientists on the team. Although not different from what she experienced academically, she recalls being asked whether she thought this environment would limit her.
“I loved being a chemical engineer and wanted to apply my skills where I’d make an impact on people’s lives. The interface of research and manufacturing was a great place to start,” said Mohan.
Tasked with developing and scaling up processes to safely, innovatively and robustly produce drug candidates for clinical trials and commercial use — these teams deliver for patients through cutting-edge science. They challenge the status-quo and try new things. That’s also how they recognize and develop talent.
“We’re committed to making sure everyone’s voice is heard and respected. This has allowed women to frame what technical growth looks like from our point of view, bringing diversity of thought to the problem-solving and leadership table,” said Mohan. “By challenging the status quo, we’re creating stronger, more innovative teams filled with unique scientific talent.”
Niki Patel and Cindy Hong joined our company within the past six years — both drawn, in part, to our reputation as a scientific leader committed to improving human health.
“I was very aware of the team’s novel and innovative science through publications in high-profile, peer-reviewed journals and presentations at conferences. This was a place where I wanted to do great science,” said Patel, associate principal scientist.
It was also a place where both Patel and Hong knew they’d fit in.
“I knew this environment was right for me,” said Hong. “I’ve worked with great female and male leaders since joining the company and been exposed to many different areas of expertise. I see real opportunities for growth.”
Strong networks and outreach are important to not only maintain a pipeline to potential female scientist candidates but also retain and promote those already on the team. They can include things like collaborative communities, mentor programs, publishing papers or grassroots efforts.
“For example, I’ve helped organize forums to discuss topics on diversity and inclusion and participated in career panels geared toward supporting women and underrepresented groups in the field,” said Patel.
Sometimes, that support might simply be a quick note of recognition.
“I try to acknowledge micro-accomplishments in the moment — things that seem small but are important to that person,’” said Mohan. “It’s a simple, personal way to show someone they — and their work — matter.”
In addition to kudos from colleagues, many of our female scientists have been recognized externally. In the last three years, 12 women in the department have been honored with individual awards or as key contributors in team awards. These awards include the ACS Division of Organic Chemistry Early Career Investigator, ACS WCC Rising Star, ACS Fellow, Heroes of Chemistry, the Edison Patent Award, the ACS Award for Computers in Chemistry and Pharma, and an HBA Rising Star.
“We have a high success rate,” said McCabe Dunn. “Ninety-two percent of the women we’ve nominated or renominated for individual awards have won.”
Can women have a successful career in science? Absolutely. As Mohan says, “Know your core, be true to it and value what makes you a unique asset.”
To learn more about some of our women in science, read Women in STEM at Merck share who inspires them most.
A physician committed to advancing pneumococcal disease research
Uniting research and manufacturing to help patients faster
Triple-negative breast cancer: risks, signs and symptoms, and diagnosis
The journey to invention and discovery is guided by science -- and inspired by patients
Our workforce represents the people we serve
Learn how we bring creative minds together as we aim to turn world-class research into impactful medicines and vaccines
This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2022 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). No Duty to Update The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
Blank Button Badges By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.